Humana (HUM) Stock Skyrockets on Medicare News – What Investors Must Know Today
Humana shares jumped over 6% to $272.05 midday Oct 3 after the company reported a sharp rise in Medicare Advantage star ratings for 2026. The stock rebounded from last week’s drop, which followed news of Humana cutting its Medicare Advantage footprint. Wall Street consensus remains neutral, with a $289 average price target. Year-to-date, shares are flat and about 19% below their 52-week high.